<DOC>
	<DOC>NCT00972738</DOC>
	<brief_summary>This study will assess the treatment effect of montelukast versus placebo over a 2 week period in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active comparator.</brief_summary>
	<brief_title>Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Patient has a documented history of season allergic rhinitis symptoms that flare up during the study season Patient is a nonsmoker Patient is in good general health Patient is hospitalized Patient is a woman who is &lt;8 weeks postpartum or is breastfeeding Patient has had major surgery in the past 4 weeks Patient intends to move or vacation away during the study Patient is a current or past abuser of alcohol or illicit drugs</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>